Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons E.C. de Heer

Publicaties

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Glucose and glycogen metabolism in cancer: potentials for intervention and patient selection

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma

Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer

Rational use of 18F-FDG PET/CT in patients with advanced cutaneous melanoma: A systematic review

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-18-FDG PET/CT analysis

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer

Lees meer